206 related articles for article (PubMed ID: 194537)
1. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome.
Kahan RS; Perez-Figaredo RA; Neimanis A
Arch Dermatol; 1977 Jun; 113(6):792-7. PubMed ID: 194537
[TBL] [Abstract][Full Text] [Related]
2. The glucagonoma syndrome.
Shupack JL; Berczeller PH; Stevens DM
J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
[TBL] [Abstract][Full Text] [Related]
3. Glucagonoma syndrome. Report of two cases and literature review.
Binnick AN; Spencer SK; Dennison WL; Horton ES
Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
[TBL] [Abstract][Full Text] [Related]
5. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
6. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Skouge JW; Farmer ER
Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
[No Abstract] [Full Text] [Related]
7. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
van der Loos TL; Lambrecht ER; Lambers JC
J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
[TBL] [Abstract][Full Text] [Related]
8. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
9. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Mullans EA; Cohen PR
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
[TBL] [Abstract][Full Text] [Related]
11. Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretion.
Wilkinson SM; Cartwright PH; Allen C; Reeves S; Alexander L; Byrne JP
Br J Dermatol; 1990 Dec; 123(6):801-5. PubMed ID: 2176092
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
13. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
14. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
[TBL] [Abstract][Full Text] [Related]
15. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
16. A glucagonoma syndrome.
Mallinson CN; Bloom SR; Warin AP; Salmon PR; Cox B
Lancet; 1974 Jul; 2(7871):1-5. PubMed ID: 4134714
[No Abstract] [Full Text] [Related]
17. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
[TBL] [Abstract][Full Text] [Related]
18. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
19. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
20. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
